about
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Read More
2.42
-0.07
(-2.81%)
10,542.8
XNAS Volume
XNAS 26 Feb, 2026 9:49 AM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
GRI Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..